Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Sorafenib exerts modest antitumor activity in patients with advanced hepatocellular carcinoma (HCC), and radiological progressive disease (rPD) does not always correspond to so-called clinical progressive disease (cPD). We evaluated 101 patients who initiated sorafenib treatment for HCC and assessed...

全面介紹

Na minha lista:
書目詳細資料
發表在:Diseases
Main Authors: Otsuka, Taiga, Nakashita, Shunya, Yanagita, Kimihiko, Ario, Keisuke, Kawasoe, Hiroaki, Kawazoe, Seiji, Eguchi, Yuichiro, Mizuta, Toshihiko
格式: Artigo
語言:Inglês
出版: MDPI 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548234/
https://ncbi.nlm.nih.gov/pubmed/28943609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases3020068
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍